510(k) K070804

VERIGENE SYSTEM, VERIGENE WARFARIN METABOLISM NUCLEIC ACID TEST by Nanosphere, Inc. — Product Code ODW

K070804 is an FDA 510(k) premarket notification submitted by Nanosphere, Inc. for the device "VERIGENE SYSTEM, VERIGENE WARFARIN METABOLISM NUCLEIC ACID TEST". The FDA issued a decision of Substantially Equivalent on September 17, 2007. The device falls under product code ODW (Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System), a Class II device regulated under 21 CFR 862.3360. Nanosphere, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 17, 2007
Date Received
March 23, 2007
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Device Class
Class II
Regulation Number
862.3360
Review Panel
TX
Submission Type

An in vitro diagnostic assay for use in genotyping Cytochrome P450 2C9 (CYP450 2C9) alleles. Information about the CYP2C9 genotype may be used as an aid to clinicians in determining therapeutic strategy for medications that are metabolized by the CYP2C9 gene product.